List of Acetadote drug patents

Acetadote is owned by Cumberland Pharms.

Acetadote contains Acetylcysteine.

Acetadote has a total of 5 drug patents out of which 0 drug patents have expired.

Acetadote was authorised for market use on 23 January, 2004.

Acetadote is available in injectable;intravenous dosage forms.

Acetadote can be used as method of treating acetaminophen overdose with acetylcysteine solutions, composition and method for providing a reduction in side effects for human patients in need of acetylcysteine therapy.

The generics of Acetadote are possible to be released after 06 April, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8399445 CUMBERLAND PHARMS Acetylcysteine composition and uses thereof
Aug, 2025

(2 years from now)

US8653061 CUMBERLAND PHARMS Acetylcysteine composition and uses thereof
Aug, 2025

(2 years from now)

US8148356 CUMBERLAND PHARMS Acetylcysteine composition and uses therefor
May, 2026

(3 years from now)

US9327028 CUMBERLAND PHARMS Acetylcysteine compositions and methods of use thereof
Jul, 2031

(8 years from now)

US8722738 CUMBERLAND PHARMS Acetycysteine compositions and methods of use thereof
Apr, 2032

(9 years from now)

Drugs and Companies using ACETYLCYSTEINE ingredient

Market Authorisation Date: 23 January, 2004

Treatment: Method of treating acetaminophen overdose with acetylcysteine solutions; Composition and method for providing a reduction in side effects for human patients in need of acetylcysteine therapy

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of ACETADOTE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in